Nugene International Stock Analysis

NUGN Stock  USD 0.01  0  25.00%   
NuGene International is overvalued with Real Value of 0.0048 and Hype Value of 0.006521. The main objective of NuGene International pink sheet analysis is to determine its intrinsic value, which is an estimate of what NuGene International is worth, separate from its market price. There are two main types of NuGene International's stock analysis: fundamental analysis and technical analysis.
The NuGene International pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NuGene International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

NuGene Pink Sheet Analysis Notes

The company recorded a loss per share of 0.29. NuGene International had not issued any dividends in recent years. The entity had 376:25 split on the 27th of January 2015. Livento Group, Inc. engages in the film and television production activities. Livento Group, Inc. was incorporated in 2013 and is based in New York, New York. Nugene International operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people.The quote for NuGene International is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about NuGene International contact David Stybr at 980 432 8241 or learn more at https://www.liventogroup.com.

NuGene International Investment Alerts

NuGene International generated a negative expected return over the last 90 days
NuGene International has high historical volatility and very poor performance
NuGene International has some characteristics of a very speculative penny stock
NuGene International has a very high chance of going through financial distress in the upcoming years
NuGene International currently holds 2.8 M in liabilities with Debt to Equity (D/E) ratio of 1.05, which is about average as compared to similar companies. NuGene International has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist NuGene International until it has trouble settling it off, either with new capital or with free cash flow. So, NuGene International's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NuGene International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NuGene to invest in growth at high rates of return. When we think about NuGene International's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 1.47 M. Net Loss for the year was (75.19 K) with loss before overhead, payroll, taxes, and interest of (209.4 K).
NuGene International currently holds about 118.34 K in cash with (2 M) of positive cash flow from operations.

NuGene Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.61 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NuGene International's market, we take the total number of its shares issued and multiply it by NuGene International's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

NuGene Profitablity

The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.11) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.11.

Technical Drivers

As of the 25th of November, NuGene International secures the risk adjusted performance of 0.0431, and Mean Deviation of 10.38. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NuGene International, as well as the relationship between them.

NuGene International Price Movement Analysis

Execute Study
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. NuGene International middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for NuGene International. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

NuGene International Predictive Daily Indicators

NuGene International intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NuGene International pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

NuGene International Forecast Models

NuGene International's time-series forecasting models are one of many NuGene International's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NuGene International's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About NuGene Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how NuGene International prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NuGene shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as NuGene International. By using and applying NuGene Pink Sheet analysis, traders can create a robust methodology for identifying NuGene entry and exit points for their positions.
Livento Group, Inc. engages in the film and television production activities. Livento Group, Inc. was incorporated in 2013 and is based in New York, New York. Nugene International operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding NuGene International to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

Other Information on Investing in NuGene Pink Sheet

NuGene International financial ratios help investors to determine whether NuGene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NuGene with respect to the benefits of owning NuGene International security.